XML 39 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2025
Income Taxes [Abstract] |
Income Taxes | 11. Income Taxes Domestic and international pre-tax loss consists of the following:
|  | December 31, |
|  | 2025 |  |  | 2024 Restated |
United States |  |  | (23,469,273 | ) |  |  | (33,335,579 | )
International |  |  | - |  |  |  | - |
Loss before income taxes |  |  | (23,469,273 | ) |  |  | (33,335,579 | )
For the years ended December 31, 2025 and 2024, income tax expense attributable to operations is immaterial. Income tax expense differed from the amount computed by applying the federal statutory income tax rate of 21% to pretax income for the years ended December 31, 2025 and 2024 as a result of the following:
|  | December 31, 2025 |
|  | Amount |  |  | Percent |
US Federal Statutory Tax Rate |  | $ | (4,928,547 | ) |  |  | 21.00 | %
State and Local Income Taxes (1) |  |  | (211,513 | ) |  |  | 0.90 |
Foreign Tax Effects |  |  | - |  |  |  | 0.00 |
Tax Credits |  |  | (1,010,247 | ) |  |  | 4.30 |
Change in Valuation Allowance |  |  | 4,421,241 |  |  |  | (18.84 | )
Nontaxable or Nondeductible Items |  |  |  |  |  |  |  |
Section 162m Limitation |  |  | 262,808 |  |  |  | (1.12 | )
Warrant Revaluation |  |  | 248,946 |  |  |  | (1.06 | )
Other permanent differences |  |  | 236,687 |  |  |  | (1.01 | )
Change in unrecognized tax benefits |  |  | 303,074 |  |  |  | (1.29 | )
Other Reconciling Items |  |  |  |  |  |  |  |
Deferred True Up |  |  | 622,366 |  |  |  | (2.65 | )
Other |  |  | 55,184 |  |  |  | (0.24 | )
Total |  | $ | - |  |  |  | 0.00 | %
(1) | For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent) of the tax effect in this category.
|  | December 31, 2024 |
Federal tax at statutory rate |  | $ | (6,142,980 | )
State income taxes |  |  | (218,456 | )
Stock based compensation |  |  | 180,319 |
Foreign taxes |  |  | - |
Tax credits |  |  | (1,039,015 | )
Nondeductible items |  |  | 26,970 |
Valuation allowance |  |  | 5,327,801 |
Deferred true up |  |  | 1,165,581 |
Rate change |  |  | 717,809 |
Other items |  |  | (18,029 | )
Total |  | $ | - |
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities as of December 31, 2025 and 2024 are as following:
|  | December 31, |
|  | 2025 |  |  | 2024 |
Deferred tax assets: |  |  |  |  |  |
Net operating loss carryforwards |  | $ | 41,820,615 |  |  | $ | 36,178,997 |
Research and development credits |  |  | 7,713,764 |  |  |  | 7,006,591 |
Intangibles |  |  | 616,331 |  |  |  | 880,481 |
Fixed assets |  |  | (365,067 | ) |  |  | (181,103 | )
Stock based compensation |  |  | 27,813 |  |  |  | 452,339 |
Accruals and reserves |  |  | 441,240 |  |  |  | 281,367 |
Deferred revenue |  |  | 155,914 |  |  |  | 21,751 |
Lease liability |  |  | 1,491,200 |  |  |  | 69,025 |
Capitalized research costs |  |  | 3,761,293 |  |  |  | 5,280,797 |
Other |  |  | 223 |  |  |  | 8,639 |
Gross deferred tax assets |  |  | 55,663,326 |  |  |  | 49,998,884 |
Valuation allowance |  |  | (54,355,211 | ) |  |  | (49,934,084 | )
Total deferred tax assets |  |  | 1,308,115 |  |  |  | 64,800 |
Deferred tax liabilities: |  |  |  |  |  |  |  |
Right of use asset |  |  | (1,308,115 | ) |  |  | (64,800 | )
Deferred project costs |  |  |  |  |  |  | - |
Total deferred tax liabilities |  |  | (1,308,115 | ) |  |  | (64,800 | )
Net deferred tax assets |  | $ | - |  |  |  | - |
Management regularly assesses the ability to realize deferred tax assets recorded based upon the weight of available evidence, including such factors as recent earnings history and expected future taxable income on a jurisdiction by jurisdiction basis. In the event that the Company changes its determination as to the amount of realizable deferred tax assets, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made. The Company’s management believes that, based on a number of factors, it is more likely than not, that all or some portion of the deferred tax assets will not be realized; and accordingly, for the year ended December 31, 2025, the Company has provided a valuation allowance against the Company’s U.S. net deferred tax assets. The net change in the valuation allowance for the years ended December 31, 2025 and 2024 was an increase of $4,421,241 and $5,327,800, respectively. As of December 31, 2025, the Company had net operating loss carryforwards for federal and state income tax purposes of approximately $161,732,697 and $120,845,916, respectively, which will begin to expire in 2034 and 2035 with $126,395,500 of our federal net operating loss carryforward lasting indefinitely. As of December 31, 2025, the Company had federal and state research credit carryforwards of approximately $7,526,906 and $4,421,211, respectively. The federal research credit carryforwards will begin to expire in 2033 while the California research credits carry forward have an indefinite life. The Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of net operating losses in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use net operating losses may be limited as prescribed under Internal Revenue Code Section 382 (“IRC Section 382”). Events which may cause limitations in the amount of the net operating losses that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the federal and state net operating losses may be subject to substantial annual limitation due to the ownership change limitations provided by the IRC Section 382 and similar state provisions. Effective for tax years beginning after December 31, 2021, the Tax Cuts and Jobs Act of 2017 eliminates the option to deduct research and development expenditures currently and requires taxpayers to amortize such costs over a period of five or fifteen years. While it is possible that Congress may modify, defer, or repeal such provision, we have no assurance that the provision will be modified, deferred or repealed. This legislation has accelerated the utilization of our net operating losses in the U.S., but it has not impacted our current tax obligations. In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations, and an option to defer payroll tax payments for a limited period. In 2023, we assessed our eligibility to claim a refund of employer taxes available under the Employee Retention Credit provisions of the CARES Act. For the year ended December 31, 2023, we calculated eligible credits of approximately $763,624 provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses. As of December 31, 2025 and 2024, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets. The following table reflects changes in gross unrecognized tax benefits:
|  | December 31, |
|  | 2025 |  |  | 2024 |
Balance at beginning of year |  | $ | 3,002,825 |  |  | $ | 2,545,189 |
Increase in balance related to tax positions taken during the current year |  |  | 303,074 |  |  |  | 445,293 |
Increase in balance related to tax positions taken during prior years |  |  | - |  |  |  | 12,343 |
Decrease in balance related to prior year tax positions |  |  | - |  |  |  | - |
Decrease in balance related to settlement with tax authorities |  |  | - |  |  |  | - |
Balance at end of year |  | $ | 3,305,899 |  |  | $ | 3,002,825 |
As of December 31, 2025 and 2024, the total amount of gross unrecognized tax benefits was $3,305,899 and $3,002,825, respectively, which does not include any reserved interest or penalties. As of December 31, 2025, $3,305,899 of the total unrecognized tax benefits, if recognized, would have an impact on the Company’s effective tax rate. The Company estimates that there will be no material changes in its uncertain tax positions in the next 12 months. The Company’s has not recorded any interest or penalties related to its unrecognized tax benefits for 2025 or 2024. The Company files income tax returns in the U.S. federal and various state jurisdictions with varying statutes of limitations. The Company is generally no longer subject to tax examinations for years prior to 2021 for federal purposes and 2020 for state purposes, except in certain limited circumstances. However, due to the fact that the Company had loss and credits carried forward in some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant taxing authority through an adjustment to tax attributes carried forward to open years. The Company’s NOL and credit carryforwards from all years may be subject to adjustment for three (or four for certain states) following the year in which utilized. The Company does not anticipate that any potential tax adjustments will have a significant impact on our financial position or results of operations.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration